Interaction of folate and homocysteine pathway genotypes evaluated in susceptibility to neural tube defects (NTD) in a German population

被引:51
作者
Richter, B
Stegmann, K
Röper, B
Böddeker, I
Ngo, ETKM
Koch, MC
机构
[1] Zentrum Humangenet, D-35037 Marburg, Germany
[2] Univ Marburg, Zentrum Methodenwissensch & Gesundheitsforsch, Inst Med Biometrie & Epidemiol, Marburg, Germany
关键词
neural tube defects; MTHFR 677C -> T; MTHFR 1298A -> C; cystathionine beta-synthase; CBS; 844ins68; genotype interaction;
D O I
10.1007/s100380170096
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Neural tube defects (NTD) are likely to result from an interaction of several genes and environmental factors. Because periconceptional folate intake reduces the NTD risk in the fetus, and because mothers of children with NTD showed elevated plasma homocysteine levels, gene polymorphisms of the folate and homocysteine pathway, such as 5,10-methylenetetrahydrofolate reductase (MTHFR) 677C -->T, MTHFR 1298A -->C and cystathionine beta -synthase (CBS) 844ins68, have been implicated in the etiology of NTD. Several studies have demonstrated that these polymorphisms may indeed be associated with NTD in some populations. In order to evaluate the role of these polymorphisms and their interaction in NTD, we genotyped 417 individuals for case-control studies and 129 families for transmission disequilibrium tests. We are the first to present detailed data on MTHFR haploid genotypes in combination with CBS 844ins68. The MTHFR risk genotype 677CT/1298AC, known to be associated with decreased enzyme activity and increased homocysteine, was found significantly more often in patients than in controls (P = 0.02). A CBS insertion allele in addition to MTHFR 677CT/1298AC heterozygosity or MTHFR 677TT/1298AA homozygosity did not result in an increased risk for NTD. This is in agreement with the recently reported homocysteine-lowering effect of the CBS 844ins68 allele in carriers of MTHFR variants.
引用
收藏
页码:105 / 109
页数:5
相关论文
共 45 条
  • [31] The thermolabile variant of methylenetetrahydrofolate reductase (MTHFR) is not a major risk factor for neural tube defect in American Caucasians
    Speer, MC
    Worley, G
    Mackey, JF
    Melvin, E
    Oakes, WJ
    George, TM
    [J]. NEUROGENETICS, 1997, 1 (02) : 149 - 150
  • [32] Possible interaction of genotypes at cystathionine beta-synthase and methylenetetrahydrofolate reductase (MTHFR) in neural tube defects
    Speer, MC
    Nye, J
    McLone, D
    Worley, G
    Melvin, EC
    Viles, KD
    Franklin, A
    Drake, C
    Mackey, J
    George, TM
    [J]. CLINICAL GENETICS, 1999, 56 (02) : 142 - 144
  • [33] Stegmann K, 1999, AM J MED GENET, V87, P23, DOI 10.1002/(SICI)1096-8628(19991105)87:1<23::AID-AJMG5>3.0.CO
  • [34] 2-E
  • [35] Sun FZ, 1999, AM J EPIDEMIOL, V150, P97
  • [36] Trembath D, 1999, TERATOLOGY, V59, P331, DOI 10.1002/(SICI)1096-9926(199905)59:5<331::AID-TERA4>3.0.CO
  • [37] 2-L
  • [38] Tsai MY, 1996, AM J HUM GENET, V59, P1262
  • [39] Relation between plasma homocysteine concentration, the 844ins68 variant of the cystathionine β-synthase gene, and pyridoxal-5′-phosphate concentration
    Tsai, MY
    Yang, F
    Bignell, M
    Aras, Ö
    Hanson, NQ
    [J]. MOLECULAR GENETICS AND METABOLISM, 1999, 67 (04) : 352 - 356
  • [40] A second common mutation in the methylenetetrahydrofolate reductase gene:: An additional risk factor for neural-tube defects?
    van der Put, NMJ
    Gabreëls, F
    Stevens, EMB
    Smeitink, JAM
    Trijbels, FJM
    Eskes, TKAB
    van den Heuvel, LP
    Blom, HJ
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (05) : 1044 - 1051